A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session

Journal of Urology

Volumn 170, Issue 4 I, 2003, Pages 1184-1188

  Lopez Corona, Ernesto ^a   Ohori, Makoto ^a   Scardino, Peter T ^a   Reuter, Victor E ^a   Gonen, Mithat ^a   Kattan, Michael W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Prostate; Prostatic neoplasms; Risk biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RISK FACTOR;

EID: 0041691119     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000087451.64657.fa     Document Type: Article

References (20)

1. Jemal, A., Thomas, A., Murray, T. and Thun, M.: Cancer statistics, 2002. CA Cancer J Clin, 52: 23, 2002
2. O'Dowd, G. J., Miller, M. C., Orozco, R. and Veltri, R. W.: Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology, 55: 553, 2000
3. Keetch, D. W., Catalona, W. J. and Smith, D. S.: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol, 151: 1571, 1994
4. Keetch, D. W., McMurtry, J. M., Smith, D. S., Andriole, G. L. and Catalona, W. J.: Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J Urol, 156: 428, 1996
5. Fowler, J. E., Jr., Bigler, S. A., Miles, D. and Yalkut, D. A.: Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol, 163: 813, 2000
6. Djavan, B., Zlotta, A., Remzi, M., Ghawidel, K., Basharkhah, A., Schulman, C. C. et al: Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol, 163: 1144, 2000
7. Epstein, J. I. and Potter, S. R.: The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol, 166: 402, 2001
8. Vis, A. N., Hoedemaeker, R. F., Roobol, M., Schroder, F. H. and van der Kwast, T. H.: The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer. Cancer, 92: 524, 2001
9. Roehrborn, C. G., Pickens, G. J. and Sanders, J. S.: Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. Urology, 47: 347, 1996
10. Ellis, W. J. and Brawer, M. K.: Repeat prostate needle biopsy: who needs it? J Urol, 153: 1496, 1995
11. Fleshner, N. E., O'Sullivan, M. and Fair, W. R.: Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol, 158: 505, 1997
12. Epstein, J. I.: Atypical small acinar proliferation of the prostate gland. Am J Surg Pathol, 22: 1430, 1998
13. Carlson, G. D., Calvanese, C. B. and Partin, A. W.: An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. Urology, 52: 455, 1998
14. Djavan, B., Remzi, M., Zlotta, A., Seitz, C., Snow, P. and Marberger, M.: Novel artificial neural network for early detection of prostate cancer. J Clin Oncol, 20: 921, 2002
15. Eastham, J. A., May, R., Robertson, J. L., Sartor, O. and Kattan, M. W.: Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. Urology, 54: 709, 1999
16. Djavan, B., Zlotta, A., Kratzik, C., Remzi, M., Seitz, C., Schulman, C. C. et al: PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL. Urology, 54: 517, 1999
17. Roehl, K. A., Antenor, J. A. V. and Catalona, W. J.: Serial biopsy results in prostate cancer screening study. J Urol, 167: 2435, 2002
18. Hayek, O. R., Noble, C. B., de la Taille, A., Bagiella, E. and Benson, M. C.: The necessity of a second prostate biopsy cannot be predicted by PSA or PSA derivatives (density or free: total ratio) in men with prior negative prostatic biopsies. Curr Opin Urol, 9: 371, 1999
19. Perrotti, M., Han, K.-R., Epstein, R. E., Kennedy, E. C., Rabbani, F., Badani, K. et al: Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol, 162: 1314, 1999
20. Epstein, J. I., Walsh, P. C., Akingba, G. and Carter, H. B.: The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. J Urol, 162: 1649, 1999